Dozens of donors and their guests gathered at the John W. and Jeanne M. Rowe Center for Research in Virology on April 30 to get a hands-on, up-close look at Morgridge Institute science.
Category: Advancement
Morgridge Institute CEO Brad Schwartz announces retirement
After more than 13 years as CEO of the Morgridge Institute, Brad Schwartz has announced plans to retire. Creating new possibilities for what contemporary science can be, under his tenure Morgridge championed curiosity-driven research, ushered in major new campus partnerships, and deepened our connection to society through mission-driven public engagement.
When the box pushes back: Reflections on the spirit of resilience at Morgridge and WARF
Roma Broadberry has a unique perspective on Wisconsin science, as both a biophysics Ph.D. student in the Tim Grant Lab at Morgridge, and a WARF ambassador. Broadberry reflects on the resilience that helps both organizations thrive in challenging times.
Celebrating the 50th anniversary of Nobel laureate Howard Temin
The scientific community celebrated the 50th anniversary of Howard Temin receiving the Nobel Prize for the discovery of reverse transcriptase with a daylong symposium event at UW–Madison.
50% of cancer cell therapy fails. Scientists developing a screening to predict success
There’s no patient fitness screening method in place for cell therapies, so Morgridge Investigator Melissa Skala’s lab is building one.